Who will respond to type I interferon receptor blockade in SLE?
Lancet Rheumatol
.
2022 Apr;4(4):e234-e236.
doi: 10.1016/S2665-9913(21)00370-2.
Epub 2022 Feb 3.
Author
Martin Aringer
1
Affiliation
1
Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. Electronic address: martin.aringer@uniklinikum-dresden.de.
PMID:
38288920
DOI:
10.1016/S2665-9913(21)00370-2
No abstract available